{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T06:36:25Z","timestamp":1762929385499,"version":"3.45.0"},"reference-count":45,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Preeclampsia (PE) remains a leading cause of maternal and fetal morbidity and mortality worldwide, yet the precise molecular mechanisms driving its pathology are not fully understood. Recent research has established extracellular vesicles (EVs) as critical mediators in the development of PE-related vascular dysfunction. These nanosized, lipid-bound particles are secreted by cells and serve as a sophisticated system of intercellular communication, carrying functionally active cargo\u2014including proteins, nucleic acids, and lipids\u2014that can modulate physiological and pathological processes via autocrine, paracrine, and endocrine signaling. While the role of EVs-mediated communication in PE has been extensively studied, the specific functions of individual protein components within this cargo remain largely unexplored. Vasorin (VASN), a known regulator of the TGF-\u03b2 signaling pathway, is a promising candidate for investigation in pregnancy disorder. This review synthesizes existing evidence on VASN's role in PE and discusses its potential contributions to disease pathogenesis. We will highlight the critical need for future research to elucidate VASN's function and evaluate its activity as a promising new therapeutic strategy for a spectrum of pregnancy-related disorders.<\/jats:p>","DOI":"10.3389\/fcvm.2025.1703770","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T06:32:12Z","timestamp":1762929132000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Vasorin at the crossroads: charting new paths in preeclampsia research"],"prefix":"10.3389","volume":"12","author":[{"given":"Saravanakumar","family":"Murugesan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakshmi","family":"Saravanakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Carlose","family":"Fernandez-Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamas","family":"Jilling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan E.","family":"Berkowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/AOG.0000000000003891","article-title":"ACOG practice bulletin No. 202: gestational hypertension and preeclampsia","volume":"133","year":"2019","journal-title":"Obstet Gynecol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"544.e1","DOI":"10.1016\/j.ajog.2013.08.019","article-title":"Incidence of preeclampsia: risk factors and outcomes associated with early-versus late-onset disease","volume":"209","author":"Lisonkova","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/nure.12055","article-title":"Epidemiology of preeclampsia: impact of obesity","volume":"71","author":"Jeyabalan","year":"2013","journal-title":"Nutr Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e023079","DOI":"10.1161\/JAHA.121.023079","article-title":"Pregnancy complications and risk of cardiovascular disease later in life: a nationwide cohort study","volume":"11","author":"Cederl\u00f6f","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1161\/CIRCULATIONAHA.118.038080","article-title":"Preeclampsia and cardiovascular disease in a large UK pregnancy cohort of linked electronic health records: a caliber study","volume":"140","author":"Leon","year":"2019","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"295.e1","DOI":"10.1016\/j.ajog.2017.06.012","article-title":"Short-term costs of preeclampsia to the United States health care system","volume":"217","author":"Stevens","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"350.e1","DOI":"10.1016\/j.ajog.2024.01.034","article-title":"Normotensive placental extracellular vesicles provide long-term protection against hypertension and cardiovascular disease","volume":"231","author":"Feng","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1161\/HYPERTENSIONAHA.123.21049","article-title":"Exocounter assays identify women who may develop early-onset preeclampsia from 12.5 \u03bcl first-trimester serum by characterizing placental small extracellular vesicles","volume":"80","author":"Chen","year":"2023","journal-title":"Hypertension"},{"key":"B9","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.2147\/IJN.S463296","article-title":"The landscape of exosomes biogenesis to clinical applications","volume":"19","author":"Al-Madhagi","year":"2024","journal-title":"Int J Nanomed"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1517\/14728222.2015.1067684","article-title":"Genetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy","volume":"19","author":"Ali","year":"2015","journal-title":"Expert Opin Ther Targets"},{"key":"B11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.14310\/horm.2002.1614","article-title":"Pregnancy-induced hypertension","volume":"14","author":"Kintiraki","year":"2015","journal-title":"Hormones (Basel)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e98667","DOI":"10.1371\/journal.pone.0098667","article-title":"A gestational profile of placental exosomes in maternal plasma and their effects on endothelial cell migration","volume":"9","author":"Salomon","year":"2014","journal-title":"PLoS One"},{"key":"B13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3389\/fphar.2014.00175","article-title":"Extravillous trophoblast cells-derived exosomes promote vascular smooth muscle cell migration","volume":"5","author":"Salomon","year":"2014","journal-title":"Front Pharmacol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1411424","DOI":"10.3389\/fcvm.2024.1411424","article-title":"Hypertensive disorders of pregnancy & vascular dysfunction","volume":"11","author":"Shah","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1161\/HYPERTENSIONAHA.123.21205","article-title":"Placenta-derived extracellular vesicles from preeclamptic pregnancies impair vascular endothelial function via lectin-like oxidized LDL receptor-1","volume":"80","author":"Galarza-Mu\u00f1oz","year":"2023","journal-title":"Hypertension"},{"key":"B16","doi-asserted-by":"publisher","first-page":"C1155","DOI":"10.1152\/ajpcell.00409.2024","article-title":"Placental extracellular vesicles from women with severe preeclampsia alter calcium homeostasis in cardiomyocytes: an ex vivo study","volume":"327","author":"Murugesan","year":"2024","journal-title":"Am J Physiol Cell Physiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1200674","DOI":"10.3389\/fcvm.2023.1200674","article-title":"Novel exosomal miRNAs associated with angiogenesis and inflammation in preeclampsia: a systematic review","volume":"10","author":"Yang","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mam.2016.10.003","article-title":"Extracellular vesicles as a new paradigm for intercellular communication in physiology and disease","volume":"53","author":"Zabeida","year":"2017","journal-title":"Mol Aspects Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3390\/cells7080093","article-title":"The role of extracellular vesicles in cancer: cargo, function, and therapeutic implication","volume":"7","author":"James","year":"2018","journal-title":"Cells"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/6196238","article-title":"Extracellular vesicles from mesenchymal stem cells: a novel cell-free therapy for tissue repair","volume":"2016","author":"Cai","year":"2016","journal-title":"Stem Cells Int"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e002621","DOI":"10.1161\/JAHA.115.002621","article-title":"Plasma exosomes from preeclampsia patients cause endothelial dysfunction by delivering sFlt-1 and sEng to the endothelium","volume":"5","author":"Chang","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2018.00335","article-title":"From vascular smooth muscle cells to folliculogenesis: what about vasorin?","volume":"5","author":"Bonnet","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.bbrc.2005.08.071","article-title":"Slit-like 2, a novel zebrafish slit homologue that might involve in zebrafish central neural and vascular morphogenesis","volume":"336","author":"Chen","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"B24","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/prca.200900196","article-title":"Identification of diabetic nephropathy-selective proteins in human plasma by multi-lectin affinity chromatography and LC-MS\/MS","volume":"4","author":"Ahn","year":"2010","journal-title":"Proteomics Clin Appl"},{"key":"B25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12953-019-0155-y","article-title":"Chronic kidney disease: a review of proteomic and metabolomic approaches to membranous glomerulonephritis, focal segmental glomerulosclerosis, and IgA nephropathy biomarkers","volume":"17","author":"Taherkhani","year":"2019","journal-title":"Proteome Sci"},{"key":"B26","first-page":"239","article-title":"Diagnostic urinary proteome profile for immunoglobulin a nephropathy","volume":"9","author":"Samavat","year":"2015","journal-title":"Iran J Kidney Dis"},{"key":"B27","doi-asserted-by":"publisher","first-page":"10732","DOI":"10.1073\/pnas.0404117101","article-title":"Vasorin, a transforming growth factor beta-binding protein expressed in vascular smooth muscle cells, modulates the arterial response to injury in vivo","volume":"101","author":"Ikeda","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2174\/1570161052773951","article-title":"Transforming growth factor-beta, cell signaling and cardiovascular disorders","volume":"3","author":"Agrotis","year":"2005","journal-title":"Curr Vasc Pharmacol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"C1560","DOI":"10.1152\/ajpcell.00221.2004","article-title":"Transforming growth factor-beta1 signaling contributes to development of smooth muscle cells from embryonic stem cells","volume":"287","author":"Sinha","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1038\/onc.2010.565","article-title":"ADAM17 (TACE) regulates TGFbeta signaling through the cleavage of vasorin","volume":"30","author":"Malapeira","year":"2011","journal-title":"Oncogene"},{"key":"B31","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.molcel.2011.05.021","article-title":"A HIF-1 target, ATIA, protects cells from apoptosis by modulating the mitochondrial thioredoxin, TRX2","volume":"42","author":"Choksi","year":"2011","journal-title":"Mol Cell"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2224457","DOI":"10.1080\/09513590.2023.2224457","article-title":"Evidence for the expression of vasorin in the human female reproductive tissues","volume":"39","author":"Taggi","year":"2023","journal-title":"Gynecol Endocrinol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2273282","DOI":"10.1080\/09513590.2023.2273282","article-title":"Vasorin: a new molecule in human reproduction?","volume":"39","author":"La Marca","year":"2023","journal-title":"Gynecol Endocrinol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1210\/en.2018-00041","article-title":"Vasorin: a novel target of luteinizing hormone in granulosa cells","volume":"159","author":"Rimon-Dahari","year":"2018","journal-title":"Endocrinology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/bies.10165","article-title":"Defining the actions of transforming growth factor beta in reproduction","volume":"24","author":"Ingman","year":"2002","journal-title":"Bioessays"},{"key":"B36","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3390\/antiox9040287","article-title":"Reactive oxygen species and male fertility","volume":"9","author":"O\u2019Flaherty","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e037242","DOI":"10.1161\/JAHA.124.037242","article-title":"Decreased extracellular vesicle vasorin in severe preeclampsia plasma mediates endothelial dysfunction","volume":"14","author":"Murugesan","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"B38","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1161\/CIRCRESAHA.111.260013","article-title":"Angiogenic factors and preeclampsia: from bench to bedside","volume":"110","author":"Rana","year":"2012","journal-title":"Circ Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-07204-7","article-title":"Vasorin is an essential negative regulator of TGF-\u03b2 signaling and vascular integrity","volume":"9","author":"Min","year":"2018","journal-title":"Nat Commun"},{"key":"B41","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.yjmcc.2020.10.007","article-title":"Vasorin-mediated TGF-\u03b2 signaling regulates endothelial to mesenchymal transition in pulmonary hypertension","volume":"149","author":"Li","year":"2020","journal-title":"J Mol Cell Cardiol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"k2371","DOI":"10.1136\/bmj.k2371","article-title":"Pre-eclampsia: pathogenesis and clinical implications","volume":"361","author":"Burton","year":"2018","journal-title":"Br Med J"},{"key":"B43","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1080\/10641955.2019.1627931","article-title":"Soluble endoglin and transforming growth factor \u03b2 in preeclampsia","volume":"38","author":"Vrachnis","year":"2019","journal-title":"Hypertens Pregnancy"},{"key":"B44","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ajog.2014.07.003","article-title":"The sFlt-1\/PlGF ratio in the management of preeclampsia","volume":"211","author":"Verlohren","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"456","DOI":"10.3389\/fcvm.2020.00456","article-title":"The role of vasorin in placental EV trafficking","volume":"15","author":"Smith","year":"2020","journal-title":"Front Cardiovasc Med"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1703770\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T06:32:13Z","timestamp":1762929133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1703770\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":45,"alternative-id":["10.3389\/fcvm.2025.1703770"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1703770","relation":{},"ISSN":["2297-055X"],"issn-type":[{"type":"electronic","value":"2297-055X"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"article-number":"1703770"}}